ARCHIVES

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

This article is from The Cancer Letter archive.

Vol. 14 No. 24 | June 10, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

BSA Approves Six Concepts

July 19, 2013

Researchers Uncover Tumors Sensitive to Chemotherapy

January 25, 2013

Clinical Education Program Phase Out Opposed By NCAB Committee

February 14, 1986

Drug Development Committee Demands, Gets Greater Voice In Contract Awards, Review of Unsolicited Proposals, Suggests RFP For New Screening Systems

January 2, 1976

In Brief: House Appropriations Committee Gives NCI $725 Million, Smallest Increase Since 1970

June 1, 1975